Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Catégories
Documents disponibles dans cette catégorie (5)
Faire une suggestion Affiner la recherche
Approches thérapeutiques médicamenteuses dans les troubles du spectre autistique / Catherine COLINEAUX
Titre : Approches thérapeutiques médicamenteuses dans les troubles du spectre autistique Type de document : Texte imprimé et/ou numérique Auteurs : Catherine COLINEAUX, Auteur Année de publication : 2012 Importance : p.113-130 Langues : Français (fre) Mots-clés : Vignette clinique Index. décimale : AUT-E AUT-E - L'Autisme - Accompagnement et Qualité de Vie Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=167 Approches thérapeutiques médicamenteuses dans les troubles du spectre autistique [Texte imprimé et/ou numérique] / Catherine COLINEAUX, Auteur . - 2012 . - p.113-130.
Langues : Français (fre)
Mots-clés : Vignette clinique Index. décimale : AUT-E AUT-E - L'Autisme - Accompagnement et Qualité de Vie Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=167 Exemplaires
Code-barres Cote Support Localisation Section Disponibilité aucun exemplaire Medication and nutritional treatments for children with ASDs / Shivani Upendra MEHTA
Titre : Medication and nutritional treatments for children with ASDs Type de document : Texte imprimé et/ou numérique Auteurs : Shivani Upendra MEHTA, Auteur ; Raghavendra Rao SIRAGAVARAPU, Auteur ; Mark E. REBER, Auteur Année de publication : 2012 Importance : p.258-284 Langues : Anglais (eng) Index. décimale : AUT-B AUT-B - L'Autisme - Ouvrages généraux et scientifiques Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=185 Medication and nutritional treatments for children with ASDs [Texte imprimé et/ou numérique] / Shivani Upendra MEHTA, Auteur ; Raghavendra Rao SIRAGAVARAPU, Auteur ; Mark E. REBER, Auteur . - 2012 . - p.258-284.
Langues : Anglais (eng)
Index. décimale : AUT-B AUT-B - L'Autisme - Ouvrages généraux et scientifiques Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=185 Exemplaires
Code-barres Cote Support Localisation Section Disponibilité aucun exemplaire Predictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems / Cristan A. FARMER in Journal of Autism and Developmental Disorders, 42-6 (June 2012)
[article]
Titre : Predictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems Type de document : Texte imprimé et/ou numérique Auteurs : Cristan A. FARMER, Auteur ; Luc LECAVALIER, Auteur ; Sunkyung YU, Auteur ; L. Eugene ARNOLD, Auteur ; Christopher J. MCDOUGLE, Auteur ; Lawrence SCAHILL, Auteur ; Benjamin L. HANDEN, Auteur ; Cynthia JOHNSON, Auteur ; Kimberly A. STIGLER, Auteur ; Karen E. BEARSS, Auteur ; Naomi SWIEZY, Auteur ; Michael G. AMAN, Auteur Année de publication : 2012 Article en page(s) : p.1037-1044 Langues : Anglais (eng) Mots-clés : Parent training Pervasive developmental disorder Autism Risperidone Predictor Moderator Index. décimale : PER Périodiques Résumé : The Research Units on Pediatric Psychopharmacology—Autism Network reported additional benefit when adding parent training (PT) to antipsychotic medication in children with autism spectrum disorders and serious behavior problems. The intent-to-treat analyses were rerun with putative predictors and moderators. The Home Situations Questionnaire (HSQ) and the Hyperactivity/Noncompliance subscale of the Aberrant Behavior Checklist were used as outcome measures. Candidate predictors and moderators included 21 demographics and baseline measures of behavior. Higher baseline HSQ scores predicted greater improvement on the HSQ regardless of treatment assignment, but no other predictors of outcome were observed. None of the variables measured in this study moderated response to PT. Antipsychotic medication plus PT appears to be equally effective for children with a wide range of demographic and behavioral characteristics. En ligne : http://dx.doi.org/10.1007/s10803-011-1338-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=156
in Journal of Autism and Developmental Disorders > 42-6 (June 2012) . - p.1037-1044[article] Predictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems [Texte imprimé et/ou numérique] / Cristan A. FARMER, Auteur ; Luc LECAVALIER, Auteur ; Sunkyung YU, Auteur ; L. Eugene ARNOLD, Auteur ; Christopher J. MCDOUGLE, Auteur ; Lawrence SCAHILL, Auteur ; Benjamin L. HANDEN, Auteur ; Cynthia JOHNSON, Auteur ; Kimberly A. STIGLER, Auteur ; Karen E. BEARSS, Auteur ; Naomi SWIEZY, Auteur ; Michael G. AMAN, Auteur . - 2012 . - p.1037-1044.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 42-6 (June 2012) . - p.1037-1044
Mots-clés : Parent training Pervasive developmental disorder Autism Risperidone Predictor Moderator Index. décimale : PER Périodiques Résumé : The Research Units on Pediatric Psychopharmacology—Autism Network reported additional benefit when adding parent training (PT) to antipsychotic medication in children with autism spectrum disorders and serious behavior problems. The intent-to-treat analyses were rerun with putative predictors and moderators. The Home Situations Questionnaire (HSQ) and the Hyperactivity/Noncompliance subscale of the Aberrant Behavior Checklist were used as outcome measures. Candidate predictors and moderators included 21 demographics and baseline measures of behavior. Higher baseline HSQ scores predicted greater improvement on the HSQ regardless of treatment assignment, but no other predictors of outcome were observed. None of the variables measured in this study moderated response to PT. Antipsychotic medication plus PT appears to be equally effective for children with a wide range of demographic and behavioral characteristics. En ligne : http://dx.doi.org/10.1007/s10803-011-1338-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=156 Psychopharmacology / Craig ERICKSON
Titre : Psychopharmacology Type de document : Texte imprimé et/ou numérique Auteurs : Craig ERICKSON, Auteur ; Kimberly A. STIGLER, Auteur ; David J. POSEY, Auteur ; Christopher J. MCDOUGLE, Auteur Année de publication : 2007 Importance : p.221-253 Langues : Anglais (eng) Index. décimale : AUT-B AUT-B - L'Autisme - Ouvrages généraux et scientifiques Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=796 Psychopharmacology [Texte imprimé et/ou numérique] / Craig ERICKSON, Auteur ; Kimberly A. STIGLER, Auteur ; David J. POSEY, Auteur ; Christopher J. MCDOUGLE, Auteur . - 2007 . - p.221-253.
Langues : Anglais (eng)
Index. décimale : AUT-B AUT-B - L'Autisme - Ouvrages généraux et scientifiques Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=796 Exemplaires
Code-barres Cote Support Localisation Section Disponibilité aucun exemplaire Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects / David COHEN in Research in Autism Spectrum Disorders, 7-1 (January 2013)
[article]
Titre : Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects Type de document : Texte imprimé et/ou numérique Auteurs : David COHEN, Auteur ; Marie RAFFIN, Auteur ; Roberto CANITANO, Auteur ; Nicolas BODEAU, Auteur ; Olivier BONNOT, Auteur ; Didier PERISSE, Auteur ; Angèle CONSOLI, Auteur ; Claudine LAURENT, Auteur Année de publication : 2013 Article en page(s) : p.167-75 Langues : Anglais (eng) Mots-clés : Second generation antipsychotics Childhood Adolescence AutismIntellectual disability Adverse effects Meta-analysis Index. décimale : PER Périodiques Résumé : Second-generation antipsychotics (SGAs) induce frequent adverse effects in children and adolescents with each compound appearing to have a specific adverse effect profile. Aripiprazole and risperidone are FDA-approved medications for behavioral disturbances associated with autism and/or intellectual disabilities (ID) in children and adolescents. Using Bayesian meta-analysis of all relevant studies (N = 8; 18 arms; 782 patients), we aimed to calculate odds ratios (OR) or mean average effects to assess efficacy, weight gain, metabolic changes, sedation, and extra-pyramidal syndrome (EPS) of the two compounds. Reporting was incomplete to assess metabolic changes. Compared to placebo, significant treatment-related increases were observed for: CGI response with aripiprazole (OR = 6.09, 95% credible interval [2.3–12.63]) and risperidone (12.8 [5.57–27.33]); weight gain with aripiprazole (OR = 6.28 [1.64–17.12]) and risperidone (7.76 [1.88–25.2]); EPS with risperidone (OR = 3.72 [1.73–7.22]); and somnolence/sedation with aripiprazole (OR = 25.76 [1.29–112.3]) and risperidone (9.63 [3.52–22.79]). There were no significant differences between active compounds. We conclude that short term efficacy of risperidone and aripiprazole are similar for behavioral disturbances associated with autism and/or ID, and that secondary effects are frequent. More research should be conducted on metabolic changes as current literature is lacking compared to other indications in youths. En ligne : http://dx.doi.org/10.1016/j.rasd.2012.08.001 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=180
in Research in Autism Spectrum Disorders > 7-1 (January 2013) . - p.167-75[article] Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects [Texte imprimé et/ou numérique] / David COHEN, Auteur ; Marie RAFFIN, Auteur ; Roberto CANITANO, Auteur ; Nicolas BODEAU, Auteur ; Olivier BONNOT, Auteur ; Didier PERISSE, Auteur ; Angèle CONSOLI, Auteur ; Claudine LAURENT, Auteur . - 2013 . - p.167-75.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 7-1 (January 2013) . - p.167-75
Mots-clés : Second generation antipsychotics Childhood Adolescence AutismIntellectual disability Adverse effects Meta-analysis Index. décimale : PER Périodiques Résumé : Second-generation antipsychotics (SGAs) induce frequent adverse effects in children and adolescents with each compound appearing to have a specific adverse effect profile. Aripiprazole and risperidone are FDA-approved medications for behavioral disturbances associated with autism and/or intellectual disabilities (ID) in children and adolescents. Using Bayesian meta-analysis of all relevant studies (N = 8; 18 arms; 782 patients), we aimed to calculate odds ratios (OR) or mean average effects to assess efficacy, weight gain, metabolic changes, sedation, and extra-pyramidal syndrome (EPS) of the two compounds. Reporting was incomplete to assess metabolic changes. Compared to placebo, significant treatment-related increases were observed for: CGI response with aripiprazole (OR = 6.09, 95% credible interval [2.3–12.63]) and risperidone (12.8 [5.57–27.33]); weight gain with aripiprazole (OR = 6.28 [1.64–17.12]) and risperidone (7.76 [1.88–25.2]); EPS with risperidone (OR = 3.72 [1.73–7.22]); and somnolence/sedation with aripiprazole (OR = 25.76 [1.29–112.3]) and risperidone (9.63 [3.52–22.79]). There were no significant differences between active compounds. We conclude that short term efficacy of risperidone and aripiprazole are similar for behavioral disturbances associated with autism and/or ID, and that secondary effects are frequent. More research should be conducted on metabolic changes as current literature is lacking compared to other indications in youths. En ligne : http://dx.doi.org/10.1016/j.rasd.2012.08.001 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=180